1. 2-Aminoimidazole-based antagonists of the 5-HT 6 receptor - A new concept in aminergic GPCR ligand design.
- Author
-
Hogendorf AS, Hogendorf A, Kurczab R, Kalinowska-Tłuścik J, Popik P, Nikiforuk A, Krawczyk M, Satała G, Lenda T, Knutelska J, Bugno R, Staroń J, Pietruś W, Matłoka M, Dubiel K, Moszczyński-Pętkowski R, Pieczykolan J, Wieczorek M, Pilarski B, Zajdel P, and Bojarski AJ
- Subjects
- Animals, Cells, Cultured, Cognitive Dysfunction chemically induced, Dose-Response Relationship, Drug, HEK293 Cells, Hep G2 Cells, Humans, Imidazoles chemical synthesis, Imidazoles chemistry, Male, Models, Molecular, Molecular Structure, Rats, Rats, Sprague-Dawley, Scopolamine administration & dosage, Serotonin Antagonists chemical synthesis, Serotonin Antagonists chemistry, Structure-Activity Relationship, Cognitive Dysfunction drug therapy, Drug Design, Imidazoles pharmacology, Receptors, Serotonin metabolism, Serotonin Antagonists pharmacology
- Abstract
A new strategy in the design of aminergic GPCR ligands is proposed - the use of aromatic, heterocyclic basic moieties in place of the evergreen piperazine or alicyclic and aliphatic amines. This hypothesis has been tested using a benchmark series of 5-HT
6 R antagonists obtained by coupling variously substituted 2-aminoimidazole moieties to the well established 1-benzenesulfonyl-1H-indoles, which served as the ligands cores. The crystallographic studies revealed that upon protonation, the 2-aminoimidazole fragment triggers a resonance driven conformational change leading to a form of higher affinity. This molecular switch may be responsible for the observed differences in 5-HT6 R activity of the studied chemotypes with different amine-like fragments. Considering the multiple functionalization sites of the embedded guanidine fragment, diverse libraries were constructed, and the relationships between the structure and activity, metabolic stability, and solubility were established. Compounds from the N-(1H-imidazol-2-yl)acylamide chemotype (10a-z) exhibited high affinity for 5-HT6 R and very high selectivity over 5-HT1A , 5-HT2A , 5-HT7 and D2 receptors (negligible binding), which was attributed to their very weak basicity. The lead compound in the series 4-methyl-5-[1-(naphthalene-1-sulfonyl)-1H-indol-3-yl]-1H-imidazol-2-amine (9i) was shown to reverse the cognitive impairment caused by the administration of scopolamine in rats indicating procognitive potential., (Copyright © 2019. Published by Elsevier Masson SAS.)- Published
- 2019
- Full Text
- View/download PDF